Cargando…
Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach
The first two oral antivirals, molnupiravir and nirmatrelvir–ritonavir, are now becoming available in many countries. These medicines will be indicated to treat mild-to-moderate COVID-19 in non-hospitalised patients who are at high risk of progressing to severe COVID-19. These antivirals should be p...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963769/ https://www.ncbi.nlm.nih.gov/pubmed/35364019 http://dx.doi.org/10.1016/S1473-3099(22)00119-0 |